Cargando…
Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome
Fragile-X syndrome (FXS) is characterized by neurological and psychiatric problems symptomatic of cortical hyperexcitability. Recent animal studies identified deficient γ-aminobutyricacid (GABA) inhibition as a key mechanism for hyperexcitability in FXS, but the GABA system remains largely unexplore...
Autores principales: | Morin-Parent, Florence, Champigny, Camille, Lacroix, Angelina, Corbin, François, Lepage, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868148/ https://www.ncbi.nlm.nih.gov/pubmed/31748507 http://dx.doi.org/10.1038/s41398-019-0650-z |
Ejemplares similares
-
Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial
por: Champigny, Camille, et al.
Publicado: (2022) -
Hyperexcitability and Homeostasis in Fragile X Syndrome
por: Liu, Xiaopeng, et al.
Publicado: (2022) -
Clinical significance of matrix metalloproteinase-9 in Fragile X Syndrome
por: Laroui, Asma, et al.
Publicado: (2022) -
Mechanisms Driving the Emergence of Neuronal Hyperexcitability in Fragile X Syndrome
por: Bülow, Pernille, et al.
Publicado: (2022) -
APP Causes Hyperexcitability in Fragile X Mice
por: Westmark, Cara J., et al.
Publicado: (2016)